Sign in Pull a receipt

MLTX

MoonLake Immunotherapeutics

Biotechnology · Biotechnology

$63.98 sample

-0.27 (-0.42%) 1D

Market cap

$246.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-21

Alerts

8

Price$63.98 -3.95% 3M daily closessample

66.6560.54

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider buy: Director
Oct 14INSInsider buy: EVP, Operations
Oct 09INSInsider sell: General Counsel
Sep 30INSInsider sell: Chief Executive Officer
Sep 25INSInsider sell: General Counsel
Sep 21SEC10-Q filed
Sep 15INSInsider sell: Director
Sep 10SECDEF 14A filed

Sign up to see the real MLTX record →

Company facts

SEC EDGAR registration

Name: MoonLake Immunotherapeutics
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +47sample, -100 to +100
Reporting currency: USD

Who is positioning in MLTX

sample

Insiders: 16 insider transactions over 90 days, net selling, $785.5M
Congress: 2 members traded over 90 days
Institutions · 13F: 30 funds hold $3.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$5.7B +18.3% y/y

Q4 2024Q3 2026

Inventory$3.3B +6.0% y/y

Q4 2024Q3 2026

Accounts receivable$2.6B +6.8% y/y

Q4 2024Q3 2026

Total debt$7.1B +15.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $237.8B -5.7% 3M
Sample peer B: $24.6B -7.5% 3M
Sample peer C: $182.1B +3.0% 3M
Sample peer D: $52.5B -8.9% 3M
Sample peer E: $95.3B +12.3% 3M